Ghost Tree Capital, LLC Vaxcyte, Inc. Transaction History

Ghost Tree Capital, LLC

$267 Million
Q3 2024

A detailed history of Ghost Tree Capital, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 80,000 shares of PCVX stock, worth $6.88 Million. This represents 3.42% of its overall portfolio holdings.

Number of Shares

80,000

Previous 150,000 46.67%

Holding current value

$6.88 Million

Previous $11.3 Million 19.36%

% of portfolio

3.42%

Previous 4.62%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$70.52 - $117.12 $4.94 Million - $8.2 Million	-70,000 Reduced 46.67%	80,000 $9.13 Million
Q2 2024 Aug 14, 2024	BUY	$60.06 - $78.77 $3.3 Million - $4.33 Million	55,000 Added 57.89%	150,000 $11.3 Million
Q1 2024 May 15, 2024	BUY	$59.79 - $81.05 $1.49 Million - $2.03 Million	25,000 Added 35.71%	95,000 $6.49 Million
Q4 2023 Feb 14, 2024	SELL	$45.35 - $63.41 $3.17 Million - $4.44 Million	-70,000 Reduced 50.0%	70,000 $4.4 Million
Q3 2023 Nov 14, 2023	SELL	$46.0 - $53.1 $6.44 Million - $7.43 Million	-140,000 Reduced 50.0%	140,000 $7.14 Million
Q2 2023 Aug 14, 2023	BUY	$34.66 - $54.07 $1.91 Million - $2.97 Million	55,000 Added 24.44%	280,000 $14 Million
Q1 2023 May 15, 2023	BUY	$36.27 - $47.2 $2.36 Million - $3.07 Million	65,000 Added 40.63%	225,000 $8.43 Million
Q4 2022 Feb 14, 2023	SELL	$20.58 - $47.95 $4.12 Million - $9.59 Million	-200,000 Reduced 55.56%	160,000 $7.67 Million
Q3 2022 Nov 14, 2022	BUY	$21.69 - $28.53 $759,150 - $998,550	35,000 Added 10.77%	360,000 $8.64 Million
Q2 2022 Aug 15, 2022	BUY	$17.68 - $26.58 $442,000 - $664,500	25,000 Added 8.33%	325,000 $7.07 Million
Q1 2022 May 16, 2022	BUY	$17.46 - $26.36 $873,000 - $1.32 Million	50,000 Added 20.0%	300,000 $7.25 Million
Q4 2021 Feb 16, 2022	BUY	$19.32 - $26.45 $1.74 Million - $2.38 Million	90,000 Added 56.25%	250,000 $5.95 Million
Q3 2021 Nov 15, 2021	BUY	$20.26 - $26.97 $303,900 - $404,550	15,000 Added 10.34%	160,000 $4.06 Million
Q2 2021 Aug 11, 2021	BUY	$16.45 - $24.06 $2.39 Million - $3.49 Million	145,000 New	145,000 $3.26 Million

Others Institutions Holding PCVX

# of Institutions

352

Shares Held

122M

Call Options Held

775K

Put Options Held

433K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $5.1B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Account

Ghost Tree Capital, LLC Vaxcyte, Inc. Transaction History